接受根治性膀胱切除术患者上尿路上皮癌的累积发病率和复发风险因素

IF 1.6 Q3 UROLOGY & NEPHROLOGY BJUI compass Pub Date : 2024-02-29 DOI:10.1002/bco2.336
Ryo Yamashita, Masafumi Nakamura, Akifumi Notsu, Koiku Asakura, Kimitsugu Usui, Yuma Sakura, Hideo Shinsaka, Masato Matsuzaki, Takashi Sugino, Ryuichi Mizuno, Masashi Niwakawa, Mototsugu Oya
{"title":"接受根治性膀胱切除术患者上尿路上皮癌的累积发病率和复发风险因素","authors":"Ryo Yamashita,&nbsp;Masafumi Nakamura,&nbsp;Akifumi Notsu,&nbsp;Koiku Asakura,&nbsp;Kimitsugu Usui,&nbsp;Yuma Sakura,&nbsp;Hideo Shinsaka,&nbsp;Masato Matsuzaki,&nbsp;Takashi Sugino,&nbsp;Ryuichi Mizuno,&nbsp;Masashi Niwakawa,&nbsp;Mototsugu Oya","doi":"10.1002/bco2.336","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Objectives</h3>\n \n <p>This study aimed to evaluate the cumulative incidence of upper tract urothelial carcinoma (UTUC) recurrence and identify its risk factors in patients who underwent radical cystectomy (RC).</p>\n </section>\n \n <section>\n \n <h3> Patients and methods</h3>\n \n <p>We performed RC on 385 patients between September 2002 and February 2020. After excluding 20 patients—13 with simultaneous nephroureterectomy, 6 with distal ureteral stump positivity and 1 with urachal cancer—365 patients were included in the analysis. To predict UTUC recurrence, we examined the cancer extension pattern in cystectomy specimens and categorized them into three types: cancer located only in the bladder (bladder-only type), cancer extending to the urethra or distal ureter (one-extension type) and cancer extending to both the urethra and distal ureter (both-extension type). We determined hazard ratios for UTUC recurrence for each covariate, including this cancer extension pattern.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>Of the 365 patients, 60% had the bladder-only type, 30% had the one-extension type and 10% had the both-extension type. During a median follow-up period of 72 months for survivors, UTUC recurred in 25 of the 365 patients, with cumulative incidences of 3.7% at 5 years and 8.3% at 10 years. The median interval from cystectomy to recurrence was 65 months (interquartile range: 36–92 months). In the multivariate analysis, the extension pattern was a significant predictor of UTUC recurrence. The hazard ratios for UTUC recurrence were 3.12 (95% confidence interval [CI] = 1.15–8.43, <i>p</i> = 0.025) for the one-extension type and 5.96 (95% CI = 1.98–17.91, <i>p</i> = 0.001) for the both-extension type compared with the bladder-only type.</p>\n </section>\n \n <section>\n \n <h3> Conclusions</h3>\n \n <p>The cancer extension pattern in cystectomy specimens is predictive of UTUC recurrence. A more extensive cancer extension in cystectomy specimens elevates the risk of subsequent UTUC recurrence. Intensive long-term monitoring is essential, particularly for patients with the both-extension type.</p>\n </section>\n </div>","PeriodicalId":72420,"journal":{"name":"BJUI compass","volume":"5 5","pages":"483-489"},"PeriodicalIF":1.6000,"publicationDate":"2024-02-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/bco2.336","citationCount":"0","resultStr":"{\"title\":\"Cumulative incidence and risk factors for recurrence of upper tract urothelial carcinoma in patients undergoing radical cystectomy\",\"authors\":\"Ryo Yamashita,&nbsp;Masafumi Nakamura,&nbsp;Akifumi Notsu,&nbsp;Koiku Asakura,&nbsp;Kimitsugu Usui,&nbsp;Yuma Sakura,&nbsp;Hideo Shinsaka,&nbsp;Masato Matsuzaki,&nbsp;Takashi Sugino,&nbsp;Ryuichi Mizuno,&nbsp;Masashi Niwakawa,&nbsp;Mototsugu Oya\",\"doi\":\"10.1002/bco2.336\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div>\\n \\n \\n <section>\\n \\n <h3> Objectives</h3>\\n \\n <p>This study aimed to evaluate the cumulative incidence of upper tract urothelial carcinoma (UTUC) recurrence and identify its risk factors in patients who underwent radical cystectomy (RC).</p>\\n </section>\\n \\n <section>\\n \\n <h3> Patients and methods</h3>\\n \\n <p>We performed RC on 385 patients between September 2002 and February 2020. After excluding 20 patients—13 with simultaneous nephroureterectomy, 6 with distal ureteral stump positivity and 1 with urachal cancer—365 patients were included in the analysis. To predict UTUC recurrence, we examined the cancer extension pattern in cystectomy specimens and categorized them into three types: cancer located only in the bladder (bladder-only type), cancer extending to the urethra or distal ureter (one-extension type) and cancer extending to both the urethra and distal ureter (both-extension type). We determined hazard ratios for UTUC recurrence for each covariate, including this cancer extension pattern.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Results</h3>\\n \\n <p>Of the 365 patients, 60% had the bladder-only type, 30% had the one-extension type and 10% had the both-extension type. During a median follow-up period of 72 months for survivors, UTUC recurred in 25 of the 365 patients, with cumulative incidences of 3.7% at 5 years and 8.3% at 10 years. The median interval from cystectomy to recurrence was 65 months (interquartile range: 36–92 months). In the multivariate analysis, the extension pattern was a significant predictor of UTUC recurrence. The hazard ratios for UTUC recurrence were 3.12 (95% confidence interval [CI] = 1.15–8.43, <i>p</i> = 0.025) for the one-extension type and 5.96 (95% CI = 1.98–17.91, <i>p</i> = 0.001) for the both-extension type compared with the bladder-only type.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Conclusions</h3>\\n \\n <p>The cancer extension pattern in cystectomy specimens is predictive of UTUC recurrence. A more extensive cancer extension in cystectomy specimens elevates the risk of subsequent UTUC recurrence. Intensive long-term monitoring is essential, particularly for patients with the both-extension type.</p>\\n </section>\\n </div>\",\"PeriodicalId\":72420,\"journal\":{\"name\":\"BJUI compass\",\"volume\":\"5 5\",\"pages\":\"483-489\"},\"PeriodicalIF\":1.6000,\"publicationDate\":\"2024-02-29\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1002/bco2.336\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"BJUI compass\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/bco2.336\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"UROLOGY & NEPHROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"BJUI compass","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/bco2.336","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0

摘要

本研究旨在评估接受根治性膀胱切除术(RC)患者的上尿路上皮癌(UTUC)复发累积发生率,并确定其风险因素。我们在 2002 年 9 月至 2020 年 2 月期间对 385 名患者进行了根治性膀胱切除术,在排除了 20 名患者(13 名同时进行了肾切除术,6 名输尿管远端残端阳性,1 名泌尿道癌患者)后,365 名患者纳入了分析。为了预测UTUC的复发,我们检查了膀胱切除标本中癌症的延伸模式,并将其分为三种类型:仅位于膀胱的癌症(仅膀胱型)、延伸至尿道或输尿管远端的癌症(单延伸型)以及同时延伸至尿道和输尿管远端的癌症(双延伸型)。在365名患者中,60%为单纯膀胱型,30%为单侧延伸型,10%为双侧延伸型。在幸存者72个月的中位随访期间,365名患者中有25人UTUC复发,5年和10年的累计发病率分别为3.7%和8.3%。从膀胱切除术到复发的中位间隔为 65 个月(四分位数间距:36-92 个月)。在多变量分析中,延伸模式是UTUC复发的重要预测因素。与纯膀胱型相比,单延伸型的UTUC复发危险比为3.12(95%置信区间[CI] = 1.15-8.43,p = 0.025),双延伸型的UTUC复发危险比为5.96(95%置信区间[CI] = 1.98-17.91,p = 0.001)。膀胱切除标本中的癌症扩展范围越广,UTUC随后复发的风险就越高。加强长期监测至关重要,尤其是对双侧延伸型患者。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

摘要图片

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Cumulative incidence and risk factors for recurrence of upper tract urothelial carcinoma in patients undergoing radical cystectomy

Objectives

This study aimed to evaluate the cumulative incidence of upper tract urothelial carcinoma (UTUC) recurrence and identify its risk factors in patients who underwent radical cystectomy (RC).

Patients and methods

We performed RC on 385 patients between September 2002 and February 2020. After excluding 20 patients—13 with simultaneous nephroureterectomy, 6 with distal ureteral stump positivity and 1 with urachal cancer—365 patients were included in the analysis. To predict UTUC recurrence, we examined the cancer extension pattern in cystectomy specimens and categorized them into three types: cancer located only in the bladder (bladder-only type), cancer extending to the urethra or distal ureter (one-extension type) and cancer extending to both the urethra and distal ureter (both-extension type). We determined hazard ratios for UTUC recurrence for each covariate, including this cancer extension pattern.

Results

Of the 365 patients, 60% had the bladder-only type, 30% had the one-extension type and 10% had the both-extension type. During a median follow-up period of 72 months for survivors, UTUC recurred in 25 of the 365 patients, with cumulative incidences of 3.7% at 5 years and 8.3% at 10 years. The median interval from cystectomy to recurrence was 65 months (interquartile range: 36–92 months). In the multivariate analysis, the extension pattern was a significant predictor of UTUC recurrence. The hazard ratios for UTUC recurrence were 3.12 (95% confidence interval [CI] = 1.15–8.43, p = 0.025) for the one-extension type and 5.96 (95% CI = 1.98–17.91, p = 0.001) for the both-extension type compared with the bladder-only type.

Conclusions

The cancer extension pattern in cystectomy specimens is predictive of UTUC recurrence. A more extensive cancer extension in cystectomy specimens elevates the risk of subsequent UTUC recurrence. Intensive long-term monitoring is essential, particularly for patients with the both-extension type.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
2.30
自引率
0.00%
发文量
0
审稿时长
12 weeks
期刊最新文献
Issue Information Issue Information Reliability of mpMRI in diagnosing cancer prostate following intravesical BCG for bladder cancer Understanding the long-term impact of the COVID-19 pandemic on non-muscle-invasive bladder cancer outcomes: 12-Month follow-up data from the international, prospective COVIDSurg Cancer study Treatment preferences of patients with muscle invasive bladder cancer: A discrete choice experiment
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1